Skip to content
OpenCapital
Get started

Innoviva, Inc. INVA Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
——

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B—
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K—
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×—
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%—
Debt / equity0.2×—
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s equity in earnings (losses) of equity method investees?
Innoviva, Inc. (INVA) reported equity in earnings (losses) of equity method investees of $157.65M in Q1 2026.
How has Innoviva, Inc.'s equity in earnings (losses) of equity method investees changed year-over-year?
Innoviva, Inc.'s equity in earnings (losses) of equity method investees increased by 1263.6% year-over-year, from -$13.55M to $157.65M.
What is the long-term trend for Innoviva, Inc.'s equity in earnings (losses) of equity method investees?
Over 4 years (2021 to 2025), Innoviva, Inc.'s equity in earnings (losses) of equity method investees has grown at a 13.8% compound annual growth rate (CAGR), from $84.39M to $141.43M.